Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone and Exercise in Type 2 Diabetes
NCT00306176Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by Aristotle University of Thessaloniki. Started Jan 2005; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00306176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306176.